Accueil / Tag Archives: Science

Tag Archives: Science

Circle Pharma Announces Expansion of Series A Financing and Appointment of James C. Lu to Its Board

Tuesday, April 25th 2017 at 11:00am UTC Funds will be used to advance Circle’s computational and synthetic chemistry platform for macrocyclic peptide therapeutics SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Circle Pharma, Inc. today announced that it has completed an expansion of its Series A financing, with new investors WI Harper Group, …

Plus »

eClinical Solutions LLC Appoints New Vice President of Biostatistics

Monday, April 24th 2017 at 7:53pm UTC MANSFIELD, Mass.–(BUSINESS WIRE)– eClinical Solutions LLC, an industry-leading provider of end-to-end data management services and technologies, announced today that Demi Niforos has joined the organization to head their biostatistics and statistical programming division. Demi Niforos comes to eClinical Solutions with a wealth of …

Plus »

AmpliPhi Biosciences Announces Presentation of Personalized Bacteriophage Therapy Case Study for Life-Threatening Antibiotic-Resistant Infection at Scientific Conference

Tuesday, April 25th 2017 at 10:50am UTC Critically ill patient successfully treated with personalized phage therapy under Emergency IND SAN DIEGO–(BUSINESS WIRE)– AmpliPhi Biosciences Corporation (NYSE MKT: APHB), a global leader in the development of therapies for drug-resistant bacterial infections using bacteriophage technology, announces that a case study highlighting the …

Plus »

Ophthotech Announces Leadership Transition Effective July 1, 2017

Monday, April 24th 2017 at 8:15pm UTC – David R. Guyer, M.D. to Transition to Executive Chairman – – Glenn P. Sblendorio to Become Chief Executive Officer – – David F. Carroll Promoted to Chief Financial Officer, Effective Immediately – NEW YORK–(BUSINESS WIRE)– Ophthotech Corporation (Nasdaq:OPHT) today announced that David …

Plus »

endpoint Enhances and Extends IRT with Latest Technology Innovation

Tuesday, April 25th 2017 at 12:00pm UTC SAN FRANCISCO–(BUSINESS WIRE)– endpoint Clinical, a leading global interactive response technology (IRT®) company, has announced a significant enhancement to its proprietary PULSE® platform, reshaping the way IRT is applied to clinical trials. “Since the initiation of endpoint in 2009, we have been continuously improving …

Plus »

EpimAb Biotherapeutics Raises $25M in Series A Financing From International Consortium to Advance Pipeline of Novel Bispecific Antibodies

Tuesday, April 25th 2017 at 4:00am UTC SHANGHAI–(BUSINESS WIRE)– EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, today announced the completion of a $25 million Series A financing round. The financing was led by Oriza Seed Capital and included investments from Decheng Capital, 3E Bioventures Capital and …

Plus »

MolecularMatch Introduces MMPower Knowledge Base – Providing One of the Industry’s Most Dynamic Molecular Search Engines

Monday, April 24th 2017 at 7:42pm UTC HOUSTON–(BUSINESS WIRE)– MolecularMatch has announced their new knowledge platform, MMPower. The Platform covers over 400 million alterations with the ability to process whole exomes in seconds. The complexity of genetic molecular data, in any format, is converted quickly by MMPower into understandable and meaningful information. “We started with some of …

Plus »

Enamine to Collaborate with EMBL for Cancer Drug Discovery Research

Tuesday, April 25th 2017 at 8:25am UTC A strategic agreement between Europe’s flagship laboratory for basic research in molecular biology and the world’s largest medicinal chemistry design house KIEV, Ukraine–(BUSINESS WIRE)– Enamine Ltd., a chemical company, producer of novel chemical building blocks and screening libraries, and the European Molecular Biology Laboratory (EMBL) …

Plus »

Transgene and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate TG4010 in Combination with Opdivo and Standard Chemotherapy in First Line Non-Small Cell Lung Cancer

Tuesday, April 25th 2017 at 5:30am UTC NEW YORK & STRASBOURG, France–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) and Transgene today announced a new clinical research collaboration to evaluate the safety, tolerability and efficacy of Transgene’s investigational therapeutic vaccine TG4010 in combination with Bristol-Myers Squibb’s Opdivo (nivolumab) + standard chemotherapy (CT) …

Plus »

Gyros Protein Technologies Signs Distribution Agreement with Luxembourg Bio Technologies for Peptide Synthesis Reagents

Tuesday, April 25th 2017 at 1:00pm UTC Agreement includes exclusive distribution of PurePep Coupling Agents in North America UPPSALA, Sweden–(BUSINESS WIRE)– Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has signed an exclusive distribution agreement with Luxembourg …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE !
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...